Atlas Trials

PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine

Clinical trial NCT04353037 · TERMINATED

Trial details

NCT number
NCT04353037
Sponsor
UnitedHealth Group
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
CoronavirusCorona Virus Infection
Start date
2020-04-07
Primary completion
2020-07-11
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.